Form 4: Medpace Holdings Exec VP Susan Burwig Sells Shares
SEC Form 4 Filing
Susan Burwig, Executive VP of Operations at Medpace Holdings, sold 102 shares of common stock on March 15, 2024.
Summary
- On March 15, 2024, Susan Burwig, the Executive VP of Operations at Medpace Holdings, sold 102 shares of the company's common stock.
- The sale was executed at a weighted average price of $403 per share, with individual transactions ranging from $403.00 to $403.14.
- The transaction was conducted under a limit order placed during an open window period.
- Following the reported transaction, Burwig beneficially owns 15,181 shares of Medpace Holdings, Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of an insider transaction. The sale of a small number of shares by an executive doesn't necessarily indicate a positive or negative outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and their holdings in the company.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but the small number of shares sold suggests it is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 03/15/2024 | Date of stock sale transaction |
| 03/19/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.